WHIPgroup has filed a Complaint before the United States International Trade Commission (ITC) on behalf of its client RegenLab USA. The Complaint alleges that RegenLab’s US Pat. No. 10.064,894, directed to a blood separator system for the preparation of platelet rich plasma, has been infringed by Estar Technologies, Ltd. and Eclipse MedCorp., LLC. RegenLab is seeking an exclusion order from the ITC to prevent importation of infringing products. The ITC instituted a formal investigation on March 7, 2019. The case is captioned In the Matter of Certain Blood Separation and Cell Preparation Devices, Inv. No. 337-TA-1147.
By: Jasmine B. Gratton, Matthew U. Silfin The U.S. Copyright Office has recently started reviewing claims at the new Copyright Claims Board (CCB). After some delay, the first claim was filed on June 16, 2022, [Read More…]
By Matthew U. Silfin, Jasmine B. Gratton Intellectual property is one of the most valuable assets a business can have, and those assets need to be protected. For many, quickly gaining intellectual property protection grants [Read More…]
By: Jasmine B. Gratton, Meghan E. McDermott The United States Patent and Trademark Office’s (USPTO) efforts to modernize its practices and increase the efficiency of examination have started to take shape. As of [Read More…]